Surrozen, Inc./DE Warrants and Rights Outstanding
Surrozen, Inc./DE (SRZN) had Warrants and Rights Outstanding of $115.00 thousand as of 2023-12-31, per its 10-K filed 2024-04-10.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:WarrantsAndRightsOutstanding · last filed 2024-04-10
- 2023-12-31: Warrants and Rights Outstanding $115.00K.
- 2023-03-31: Warrants and Rights Outstanding $591.00K.
- 2022-12-31: Warrants and Rights Outstanding $326.00K.
- 2022-09-30: Warrants and Rights Outstanding $1.33M.
| Period end | Warrants and Rights Outstanding |
|---|---|
| 2023-12-31 | $115.00K 10-K · filed 2024-04-10 |
| 2023-03-31 | $591.00K 10-Q · filed 2023-05-10 |
| 2022-12-31 | $326.00K 10-K · filed 2023-03-31 |
| 2022-09-30 | $1.33M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $1.38M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $1.80M 10-Q · filed 2022-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B |